2Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
3Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
4Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
5Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
6Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
7Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
8Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York.- citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31 : 101-106.
9Kuo L, Teng L, Yu C, et al. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol, 2004, 42: 1759-1763.
10Zarrulli R, Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergency of carbapenem resistance. J Clin Microbiol, 2004, 42: 946-953.
